期刊文献+

甲状腺乳头状腺癌E-cadherin、CD44v6的表达 被引量:5

Expressions of E-cadherin and CD44v6 in papillary thyroid carcinoma
下载PDF
导出
摘要 目的 :研究粘附分子E cadherin (E cd)、CD44v6在甲状腺乳头状腺癌 (PTC)中的表达及其与PTC转移的关系。方法 :应用免疫组化SP法 ,检测 70例PTC标本中E cd、CD44v6的表达。结果 :E cd、CD44v6在PTC中的阳性表达率分别为 44 .3%(31/ 70 ) ,6 7.1%(4 7/ 70 ) ,二者的表达呈明显的负相关 ;在有淋巴结转移组 ,E cd、CD44v6阳性率分别为 2 7.6 %,82 .8%,而在无淋巴结转移组分别为 5 6 .1%,5 6 .1%,两组之间差异均有统计学意义(P <0 .0 5 )。结论 :检测PTC中E cd、CD44v6的表达有助于其转移潜能的判定。 Aim: To investigate the expressions of epithelial cadherin (E-cd) and CD44v6 in the papillary thyroid carcinoma (PTC) and the correlation with metastasis. Methods: The expressions of E-cd and CD44v6 were detected by SP immunohistochemical technique in 70 specimens of PTC. Results: The positive rates of E-cd and CD44v6 were 44.3%(31/70) and 67.1%(47/70) respectively, and there was distinct negative correlation between the expressions of E-cd and CD44v6; the expressions of E-cd and CD44v6 in patients with lymph node metastasis were 27.6% and 82.8%, but in patients without metastasis were 56.1% and 56.1%. There was significant difference between the 2 groups (P< 0.01). Conclusion: Determination of E-cd and CD44v6 might be useful to predict the metastatic potential of PTC.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2002年第4期407-409,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省科技攻关资助项目 199932 0 0 0 9
关键词 甲状腺乳头状腺癌 E-CADHERIN CD44V6 表达 thyroid neoplasm epithelial cadherin CD44v6 metastais
  • 相关文献

参考文献3

二级参考文献12

  • 1Hirohashi. American Journal of Pathology . 1998
  • 2Graff JR,Greenberg VE,Herman JG,et al. Cancer Research . 1998
  • 3Soares P,Berx G,Van RF,et al. International Journal of Cancer . 1997
  • 4Von WR,Rhein A,Werner M,et al. Cancer Research . 1997
  • 5Scheumman GF,Huang VC,Cetin Y,et al. The Journal of Clinical Endocrinology . 1995
  • 6Huang SH,Wu JC,Chang KJ,et al. Journal of Cellular Biochemistry . 1998
  • 7Fixen UH,Behrens J,Sachs M,et al. The Journal of Cell Biology . 1991
  • 8Behrens J,Mareel MM,Roy FMV,et al. The Journal of Cell Biology . 1989
  • 9Kanai Y,Ushijima S,Hui AM,et al. International Journal of Cancer . 1997
  • 10Gullford P,Hopkins J,Harraway J,et al. Nature . 1998

共引文献19

同被引文献39

  • 1Umar A, Boyes JC, Thomas DC, et al. Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability[ J]. J Biol Chem, 1994,269(2) : 14367.
  • 2Parsons R, Li GM, Longley MJ, et al. Hypermutability and mismatch repair deficiency in RER + tumor cells[J]. Cell, 1993;75(6) :1226.
  • 3Geisler JP. Mismatch repair gene expression defects contri-bute to microsatellite instability in ovarian carcinoma [ J ]. Cancer, 2003, 98 (10) : 2199.
  • 4Uchida N, Kumimoto H, Nishizawa K, et al. Mismatch repair and Microsatelliteinstability in esophageal cancer cells[ J]. Int J Cancer, 2001,91 (3) :687.
  • 5Gotte K, Hadaczek P, Coy JF, et al. Fhit expression is absent or Reduced in a subset of primary head and neck cancer[J]. Anticancer Res,2000,20(ZA) : 1057.
  • 6Ohta M, Inoue H, Cotticelli MG, et al. The FHIT gene,spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t ( 3 ; 8 ) breakpoint, is abnormal in digestive tract cancers. Cell, 1996,84(4) :587.
  • 7Yang Q, Nakamura M, Nakamura Y, et al. Two-Hit Inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer. Clin Cancer Res,2002,8(9) :2890.
  • 8Matthews CP, Shera K, Kiviat N, et al. Expression of truncated FHIT transcripts in cervical cancers and in normal human cells. Oncogene,2001,20(34) :4665.
  • 9Deng YF, Tian F, Lu YD, et al. Mutation and abnormal expression of the fragile histidine triad gene in nasopharyngeal carcinoma. Laryngoscope ,2001,111(9) : 1589.
  • 10Ishii H, Dumon KR, Vecchione A, et al. Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells. Cancer Res,2001,61(4):1578.

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部